Efficient Repair of Human Genetic Defect by CRISPR/Cas9-mediated Interlocus Gene Conversion
Fei Yang,Yiyun Wang,Qiudao Wang,Jingtao Pang,Guolong Liu,Yang,Shenguang Qin,Ying Zhang,Yongrong Lai,Bin Fu,Yating Zhu,Mengyao Wang,Ryo Kurita,Yukio Nakamura,Dan Liang,Yuxuan Wu
DOI: https://doi.org/10.1093/lifemedi/lnad042
2023-01-01
Abstract:DNA double-strand breaks (DSBs) induced by gene-editing tools are primarily repaired through non-homologous end joining (NHEJ) or homology-directed repair (HDR) using synthetic DNA templates. However, error-prone NHEJ may result in unexpected indels at the targeted site. For most genetic disorders, precise HDR correction using exogenous homologous sequence is ideal. But, the therapeutic application of HDR might be especially challenging given the requirement for the codelivery of exogenous DNA templates with toxicity into cells, and the low efficiency of HDR could also limit its clinical application. In this study, we efficiently repair pathogenic mutations in HBB coding regions of hematopoietic stem cells (HSCs) using CRISPR/Cas9-mediated gene conversion (CRISPR/GC) using the paralog gene HBD as the internal template. After transplantation, these edited HSCs successfully repopulate the hematopoietic system and generate erythroid cells with significantly reduced thalassemia propensity. Moreover, a range of pathogenic gene mutations causing β-thalassemia in HBB coding regions were effectively converted to normal wild-type sequences without exogenous DNA templates using CRISPR/GC. This highlights the promising potential of CRISPR/GC, independent of synthetic DNA templates, for genetic disease gene therapy.